A carregar...
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor that is resistant to conventional modes of treatment with chemotherapy, surgery or radiation. Research into the molecular pathways involved in the development of MM should yield information that will guide therapeutic decisions. Epiderma...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2828989/ https://ncbi.nlm.nih.gov/pubmed/20122271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-27 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|